TL;DR: Aetna modified CPB 0552 for laser neurolysis, effective November 27, 2025. Every indication listed in this policy is denied as experimental — here's what your billing team needs to know before submitting claims.

Aetna's laser neurolysis coverage policy under CPB 0552 covers a wide range of neurolytic and neuroplasty CPT codes — 64600 through 64727 — but denies coverage when laser peripheral nerve block is the technique used. The policy calls out five specific indications as experimental, investigational, or unproven: carpal tunnel syndrome, complex regional pain syndrome, facet joint pain, phantom limb pain, and sacroiliac joint pain. If your practice performs laser neurolysis for any of these diagnoses and bills Aetna, you are looking at claim denial.


Quick-Reference: Aetna CPB 0552 Laser Neurolysis Policy

Field Detail
Payer Aetna
Policy Laser Neurolysis — CPB 0552
Policy Code CPB 0552
Change Type Modified
Effective Date November 27, 2025
Impact Level High — all listed indications denied as experimental
Specialties Affected Pain management, neurology, orthopedic surgery, physical medicine & rehabilitation
Key Action Audit any active Aetna claims or prior auth requests for laser neurolysis against the five denied indications and update your denial management workflow before billing.

Aetna Laser Neurolysis Coverage Criteria and Medical Necessity Requirements 2025

The Aetna laser neurolysis coverage policy under CPB 0552 does not establish any covered pathway for laser peripheral nerve block. This is a blanket experimental designation. There are no criteria you can meet to get laser neurolysis approved for the five listed indications.

That's the real issue here. Many payer policies on nerve procedures distinguish between covered and non-covered techniques. CPB 0552 does not. Laser neurolysis billing will result in denial regardless of the patient's diagnosis, prior treatment history, or physician documentation of medical necessity.

The broader family of neurolytic CPT codes — 64600 through 64640 and 64702 through 64727 — appears in this policy as related codes. These codes cover conventional neurolysis and neuroplasty techniques. Those procedures may be covered when medical necessity criteria are met under other Aetna policies. The denial under CPB 0552 is specific to the laser technique, not the nerve procedure category as a whole.

This distinction matters for your charge capture and prior authorization workflows. If your providers use laser as the delivery method, the technique itself triggers the experimental designation — even if the CPT code you submit (say, 64640 for destruction of a peripheral nerve) could theoretically be covered under a different approach.


Aetna Laser Neurolysis Exclusions and Non-Covered Indications

Aetna considers laser peripheral nerve block experimental, investigational, or unproven for all five of the following indications. There are no exceptions listed in the policy.

Carpal tunnel syndrome — ICD-10 codes G56.0 through G56.3 cover the full laterality range. All are denied for laser neurolysis.

Complex regional pain syndrome — This covers both CRPS Type I (G90.50–G90.59) and CRPS Type II, which Aetna codes under causalgia (G56.40–G56.42 for upper limb, G57.70–G57.73 for lower limb). Any CRPS presentation billed with laser neurolysis will be denied.

Facet joint pain — Aetna references paravertebral facet joint nerve destruction in the related CPT codes (64622–64627 range). Diagnosis codes in this area include M53.82, M53.83, and M53.0 for cervicocranial syndrome.

Phantom limb pain — ICD-10 G54.6 is the relevant code. Relatively low volume in most practices, but worth flagging for practices with amputee populations.

Sacroiliac joint pain — M53.3 is the primary diagnosis code here. This one is worth watching closely. Sacroiliac joint procedures are a high-volume area in pain management, and laser-based approaches are being marketed aggressively to practices.

The policy is explicit that this is "not an all-inclusive list." That phrase is doing real work. Aetna reserves the right to deny laser neurolysis for indications beyond these five. If you're billing laser neurolysis for any nerve condition not listed here, don't assume it's covered. Check with your compliance officer before billing.


Coverage Indications at a Glance

Indication Status Primary ICD-10 Codes Notes
Carpal tunnel syndrome ❌ Experimental/Not Covered G56.0, G56.1, G56.2, G56.3 Laser technique denied; conventional neurolysis may differ
Complex regional pain syndrome (Type I) ❌ Experimental/Not Covered G90.50–G90.59 All laterality/limb variants denied
Complex regional pain syndrome (Type II / Causalgia) ❌ Experimental/Not Covered G56.40–G56.42, G57.70–G57.73 Upper and lower limb both denied
+ 5 more indications

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

This policy is now in effect (since 2025-11-27). Verify your claims match the updated criteria above.

Aetna Laser Neurolysis Billing Guidelines and Action Items 2025

The effective date of November 27, 2025 is already past. If your team hasn't reviewed open Aetna claims or pending prior authorizations for laser neurolysis, do it now.

#Action Item
1

Pull all active Aetna claims using CPT codes 64600–64640 and 64702–64727 where the technique documented is laser-based. Any of these submitted after November 27, 2025 for the five listed indications are denial risks. Flag them for medical record review before they age out of your appeal window.

2

Update your charge capture to flag laser neurolysis when the payer is Aetna. The CPT codes themselves aren't inherently non-covered — the laser technique is the trigger. Your charge capture needs to distinguish technique, not just procedure code.

3

Note: CPB 0552 does not address prior authorization requirements. Consult Aetna's administrative guidelines for PA applicability on laser neurolysis claims.

+ 3 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Sample Version Diff Line-by-line changes
Previous VersionCurrent Version
Coverage is considered experimental and investigational for all indicationsCoverage is considered medically necessary when specific criteria are met
Prior authorization is not requiredPrior authorization is required for initial treatment
Documentation must include clinical historyDocumentation must include clinical history
+ 1 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

CPT, HCPCS, and ICD-10 Codes for Laser Neurolysis Under CPB 0552

All codes below appear in Aetna CPB 0552. These are the codes your billing team should monitor when documenting laser neurolysis procedures.

CPT Codes Referenced in CPB 0552

Code Description
64600 Destruction by neurolytic agent, trigeminal nerve
64601 Destruction by neurolytic agent, trigeminal nerve
64602 Destruction by neurolytic agent, trigeminal nerve
+ 40 more codes

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

ICD-10-CM Diagnosis Codes Under CPB 0552

The descriptions below reflect the Aetna source policy exactly. Laterality breakdowns within code ranges follow standard ICD-10-CM tabular conventions, not Aetna-specific guidance.

Code Description (per CPB 0552)
G54.6 Phantom limb syndrome with pain
G56.0 Carpal tunnel syndrome
G56.1 Carpal tunnel syndrome
+ 34 more codes

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Get the Full Picture

Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.

🔍 Search by any code 🔔 Real-time alerts 📊 Line-by-line diffs ⏰ Deadline tracking
Get Full Access → $99/mo · 14-day money-back guarantee